Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2D6 | P10635 | 1/20 | 0.37 |
| ▸ | TSHR | P16473 | 1/20 | 0.37 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.37 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5011849 | 0.90 | TSHR (0.41) | CYP2D6TSHRCYP2C19HIF1A | |
| SCHEMBL5014370 | 0.82 | CYP2D6 (0.38) | CYP2D6TSHRCYP2C19HIF1A | |
| SCHEMBL15385469 | 0.81 | MGAM (0.35) | CYP2D6TSHRCYP2C19HIF1A | |
| SCHEMBL17304528 | 0.79 | TSHR (0.39) | CYP2D6TSHRCYP2C19HIF1A | |
| SCHEMBL1086977 | 0.79 | TSHR (0.39) | CYP2D6TSHRCYP2C19HIF1A | |
| SCHEMBL17680158 | 0.78 | CYP2D6 (0.38) | CYP2D6TSHRCYP2C19HIF1A | |
| SCHEMBL10705639 | 0.75 | DGKA (0.53) | TSHR | |
| SCHEMBL17678860 | 0.75 | TSHR (0.39) | CYP2D6TSHRCYP2C19HIF1A | |
| SCHEMBL2022933 | 0.74 | CYP2D6 (0.35) | CYP2D6TSHRCYP2C19HIF1A | |
| SCHEMBL9245665 | 0.74 | TSHR (0.42) | CYP2D6TSHRCYP2C19HIF1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1319008-B1 | WATER SOLUBLE RAPAMYCIN ESTERS | WYETH CORP (US) | 2008-10-15 | — | — | EP | claimed |
| EP-1319008-A2 | WATER SOLUBLE RAPAMYCIN ESTERS | Wyeth (US) | 2003-06-18 | — | — | EP | claimed |
| US-6432973-B1 | POLYOXYETHYLATED HYDROXYESTERS OF RAPAMYCIN USEFUL IN INDUCING IMMUNOSUPPRESSION AND IN THE TREATMENT OF TRANSPLANTATION REJECTION, AUTOIMMUNE DISEASES, SOLID TUMORS, FUNGAL INFECTIONS, AND VASCULAR DISEASE. | WYETH | 2002-08-13 | — | — | US | claimed |
| US-20020055518-A1 | Water soluble rapamycin esters | AMERICAN HOME PRODUCTS CORPORATION (US) | 2002-05-09 | — | — | US | claimed |
| WO-2002024706-A2 | WATER SOLUBLE RAPAMYCIN ESTERS | WYETH (US) | 2002-03-28 | — | — | WO | claimed |
| EP-1319008-B1 | WATER SOLUBLE RAPAMYCIN ESTERS | WYETH CORP (US) | 2008-10-15 | — | — | EP | disclosed |
| EP-1319008-A2 | WATER SOLUBLE RAPAMYCIN ESTERS | Wyeth (US) | 2003-06-18 | — | — | EP | disclosed |
| US-6432973-B1 | POLYOXYETHYLATED HYDROXYESTERS OF RAPAMYCIN USEFUL IN INDUCING IMMUNOSUPPRESSION AND IN THE TREATMENT OF TRANSPLANTATION REJECTION, AUTOIMMUNE DISEASES, SOLID TUMORS, FUNGAL INFECTIONS, AND VASCULAR DISEASE. | WYETH | 2002-08-13 | — | — | US | disclosed |
| US-20020055518-A1 | Water soluble rapamycin esters | AMERICAN HOME PRODUCTS CORPORATION (US) | 2002-05-09 | — | — | US | disclosed |
| WO-2002024706-A2 | WATER SOLUBLE RAPAMYCIN ESTERS | WYETH (US) | 2002-03-28 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020055518-A1 | Water soluble rapamycin esters | RICTOR, MTOR, RPTOR | CYP2D6 2935/4885TSHR 3480/4885CYP2C19 1757/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.